The U.S. Food and Drug Administration today announced it is requesting manufacturers withdraw all prescription and over-the-counter (OTC) ranitidine drugs from the market immediately. This is the latest step in an ongoing investigation of a contaminant known as N-Nitrosodimethylamine (NDMA) in ranitidine medications (commonly known by the brand name Zantac). The agency has determined that the impurity in some ranitidine products increases over time and when stored at higher than room temperatures and may result in consumer exposure to unacceptable levels of this impurity. As a result of this immediate market withdrawal request, ranitidine products will not be available for new or existing prescriptions or OTC use in the U.S
Related Articles
Getting Students with GI Issues & Their Teachers Prepared for Back to School
As many are preparing to get their children back in school, whether in a classroom setting or via e-learning, it’s essential to make needed arrangements for those students suffering from GI issues. Advanced preparation includes scheduling a meeting with... Read More
August is Gastroparesis Month
What is Gastroparesis? Gastroparesis means paralyzed stomach. It is one of the most severe and complicated gastric motility disorders as it affects the normal spontaneous movement of the muscles (motility) in the stomach. Ordinarily, strong muscular contractions propel food... Read More